Found 34 matching trials
The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma PHASE1 This study aims to determine if the vacccine can be used safely in patients...
Show More Learn More & Join Trial
PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine PHASE2 CT-011 is an investigational monoclonal antibody. Monoclonal antibodies are...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer PHASE2 The main purpose of this study was to determine whether ADT started before ...
Show More Location
Urology Center of Alabama
Learn More & Join Trial
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. PHASE1 A multi-center, open-label, single-arm, phase I/II clinical study is design...
Show More Location
The Second Affiliated hospital of Zhejiang University School of Medicine
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia PHASE1 RATIONALE: Vaccines made from a person's white blood cells and cancer cells...
Show More Location
Cancer Research Center at Boston Medical Center
Learn More & Join Trial
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod PHASE2 This research study is evaluating the effect (good and bad) of a dendritic ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma PHASE2 RATIONALE: Vaccines made from a patient's dendritic cells may make the body...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen PHASE2 This is a randomized, multicenter, single blind, Phase 2 trial of immunothe...
Show More Location
UCSD Moores Cancer Center
Learn More & Join Trial
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML PHASE1 The goal of this research study is to test if the combination of a new T ce...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer PHASE2 This is a Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men wit...
Show More Location
Georgetown University Medical Center
Learn More & Join Trial